-
AM 281: Decoding CB1–GLT-1 Signaling
2026-09-03
AM 281 is a selective CB1 cannabinoid receptor antagonist for dissecting how endocannabinoid signaling influences glutamate homeostasis, neuronal survival, and cognition. This article translates recent CB1–CREB–GLT-1 findings into practical assay decisions while distinguishing mechanistic evidence from broader neuropharmacology applications.
-
Acetylcysteine for Redox-Aware Cancer Assays
2026-09-03
Acetylcysteine can function as more than a generic antioxidant in cancer research: it is a reversible redox perturbation for testing how oxidative conditions shape photothermal ablation and immune-remodeling assays. This guide connects NAC chemistry with the design lessons of a metastatic triple-negative breast cancer nanoplatform study.
-
Nocodazole Workflows for Microtubule Research
2026-09-02
Nocodazole offers reversible control of microtubule assembly for cell-cycle synchronization, trafficking studies, infection assays, and anticancer drug evaluation. This practical guide connects dose selection, washout design, and cytoskeletal controls to the Spiroplasma eriocheiris S2-cell model.
-
CCK-8 Ammonium: From Mechanism to Translation
2026-09-02
A translational perspective on Cholecystokinin octapeptide ammonium, connecting CCK1R and CCK2R biology with hippocampal plasticity, immune signaling, assay design, and development strategy.
-
L-Threonine in Metabolic Assay Workflows
2026-09-01
L-Threonine is a controllable nutrient variable for cell culture optimization, amino acid biosynthesis studies, and metabolic profiling—not simply a medium ingredient. This workflow connects defined L-Threonine perturbations with alkaline phosphatase readouts and a metal-free carbon-dot assay, while separating validated evidence from practical starting conditions.
-
Baicalin Methyl Ester Protects the Intestinal Barrier
2026-09-01
A 2024 study combined mouse and MODE-K cell models to show that baicalin methyl ester reduces LPS-associated intestinal inflammation and preserves tight-junction proteins. Its key mechanistic contribution was linking P65 interaction with downstream TNF-α, MLCK, and ZO-1 signaling, while also identifying practical in vivo and in vitro study parameters.
-
L-Threonine as a Metabolic Perturbation Tool
2026-08-31
L-Threonine can serve as a controlled nutrient variable for cell culture optimization, metabolic profiling, and nutritional intervention studies. This article shows how to pair its metabolic perturbation with a metal-free alkaline phosphatase assay while avoiding unsupported claims of direct enzyme inhibition.
-
Hyaluronic Acid Sodium Salt in siRNA Nanoparticles
2026-08-31
Hyaluronic acid sodium salt can serve as an extracellular matrix component and a tunable nanoparticle coating for cell-based delivery studies. This article translates a preclinical Pseudomonas aeruginosa lung-injury study into practical formulation, assay-design, troubleshooting, and validation workflows while separating reported findings from proposed starting conditions.
-
Acetylcysteine for ROS/NF-κB Cell Models
2026-08-30
Acetylcysteine provides a practical redox-control arm for senescence, neurodegeneration, hepatic protection, and respiratory disease experiments. This workflow translates a HEI-OC1 ROS/NF-κB study into dose, timing, controls, and troubleshooting decisions for reproducible bench research.
-
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-08-29
The 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ligase that weakens antiviral innate immunity by directing MAVS toward K48-linked ubiquitination and proteasomal degradation. Its gain-of-function, loss-of-function, biochemical, and animal infection experiments position ASB3–MAVS regulation as a mechanistic checkpoint connecting viral sensing to interferon production and host susceptibility.
-
7ACC2: Monocarboxylate Transporter 1 Inhibitor
2026-08-28
7ACC2 is a nanomolar carboxycoumarin tool for separating lactate transport, pyruvate handling, and radiation response in cancer models. This workflow connects metabolic phenotyping with the immunosuppressive tumor-macrophage biology highlighted in recent research, while clearly distinguishing validated findings from testable extensions.
-
Latrunculin B: From Actin Control to Translation
2026-08-28
Latrunculin B is more than an actin polymerization inhibitor: it is a time-sensitive mechanistic probe for separating cytoskeletal effects from pathway-specific biology. This thought-leadership article interprets evidence from grass carp reovirus entry studies, outlines practical validation strategies, and positions APExBIO Latrunculin B for translational cytoskeletal research.
-
BI 2536 PLK1 Inhibitor Workflows
2026-08-27
BI 2536 enables selective interrogation of PLK1-driven mitotic control, from G2/M arrest and apoptosis assays to checkpoint-complex studies. This guide connects compound handling, time-resolved cell analysis, and tumor xenograft model planning with practical troubleshooting strategies.
-
IGF2BP1–TUBB4B Signaling in Liver Fibrosis
2026-08-27
The reference study identifies an IGF2BP1–TUBB4B–FAK pathway that connects m6A-dependent RNA stabilization with hepatic stellate cell activation. Its integrated sequencing and functional perturbation strategy provides a useful framework for testing methylation-linked mechanisms while distinguishing pathway-specific effects from broader changes in cellular methyl metabolism.
-
Viral RIPK3 Degradation Controls Inflammation
2026-08-26
Liu and colleagues identified a viral inducer of RIPK3 degradation (vIRD) that connects orthopoxvirus immune evasion with SCF ubiquitin machinery and proteasomal control of necroptosis. Their genetic and infection models show that vIRD–RIPK3 interactions can alter viral replication, inflammation, and mortality in a host-dependent manner.